Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris – A randomized phase II study

Background: An aerosol foam formulation of fixed combination calcipotriene 0.005% (as hydrate; Cal) plus betamethasone dipropionate 0.064% (BD) was developed to improve psoriasis treatment. Objectives: To compare the efficacy and safety of Cal/BD aerosol foam with Cal/BD ointment after 4 weeks. Meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Koo, John, Tyring, Stephen, Werschler, William P., Bruce, Suzanne, Olesen, Martin, Villumsen, John, Bagel, Jerry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Psoriasis & Phototherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772687/
https://www.ncbi.nlm.nih.gov/pubmed/26444907
http://dx.doi.org/10.3109/09546634.2015.1083935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772687/
https://www.ncbi.nlm.nih.gov/pubmed/26444907
http://dx.doi.org/10.3109/09546634.2015.1083935

Ejemplares similares